Skip to main content
Equibles

STIFEL FINANCIAL CORP

Position in PGEN — Precigen, Inc.

CIK 720672 ST. LOUIS, MO
Back to PGEN Full portfolio

Position in PGEN

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$658,753
+$72,890 QoQ
Shares Held
115,571
-23.7% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#84
of 210 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority Sole 96% Shared 0% None 4%

Common Shares in PGEN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STIFEL FINANCIAL CORP holds $538,947,950 across 105 Biotechnology names. PGEN ranks #56 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BHVN
Biohaven Ltd.
 9,941,165 $147,924,534
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 162,151 $80,545,262
3 MANE
Veradermics, Inc
 294,117 $36,158,743
4 JAZZ
Jazz Pharmaceuticals plc
 139,491 $33,613,146
5 REGN
Regeneron Pharmaceuticals, Inc.
 46,378 $28,918,535
6 OMER
Omeros Corp
 1,836,925 $17,469,155
7 NTLA
Intellia Therapeutics, Inc.
 1,014,387 $17,163,427
8 IONS
Ionis Pharmaceuticals Inc
 202,983 $16,094,521

All Filings in PGEN

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $658,753 115,571
2026-03-31 $585,863 151,386
2025-12-31 $345,506 82,657
2025-09-30 $249,898 75,957
2025-06-30 $79,990 56,332
2025-03-31 $85,610 57,457
2024-12-31 $101,759 90,857
2024-09-30 $30,590 32,200
2024-06-30 $26,101 16,520
2024-03-31 $22,040 15,200
2023-12-31 $17,688 13,200
2023-09-30 $18,460 13,000
2023-06-30 $14,950 13,000
2023-03-31 $18,020 17,000
2020-09-30 $38,681 11,052
2020-06-30 $55,648 11,152
2020-03-31 $34,907 10,267